Latham Reps Silverfleet In $675M Sterigenics Sale
London-based Silverfleet Capital said Wednesday that it planned to turn a tidy profit from the $675 million sale of medical device and pharmaceuticals sterilization company Sterigenics International Inc. to Chicago private...To view the full article, register now.
Already a subscriber? Click here to view full article